4
Changes in Ownership
Aptevo Therapeutics Inc. Filed Acc 0001019056-20-000454
Options or other derivatives
- SVP and CFO acquired 9,520 shares (grant or award)
- SVP and CFO returned 22,193 shares (to the company)
From the SEC's structured data for this filing
Trades in this filing
Lamothe Jeffrey G. · SVP and CFO
Table II: Derivative
9 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2020-07-27 | Returned to the company : show line 1 in the form Stock Option (right to buy) | −2,695 | 0 | D |
| 2020-07-27 | Returned to the company : show line 2 in the form Stock Option (right to buy) | −1,928 | 0 | D |
| 2020-07-27 | Returned to the company : show line 3 in the form Stock Option (right to buy) | −3,128 | 0 | D |
| 2020-07-27 | Returned to the company : show line 4 in the form Stock Option (right to buy) | −2,407 | 0 | D |
| 2020-07-27 | Returned to the company : show line 5 in the form Stock Option (right to buy) | −2,407 | 0 | D |
| 2020-07-27 | Returned to the company : show line 6 in the form Stock Option (right to buy) | −4,814 | 0 | D |
| 2020-07-27 | Returned to the company : show line 7 in the form Stock Option (right to buy) | −4,814 | 0 | D |
| 2020-07-27 | Grant or award : show line 8 in the form Stock Option (right to buy) | +7,380 | 7,380 | D |
| 2020-07-27 | Grant or award : show line 9 in the form Stock Option (right to buy) | +2,140 | 2,140 | D |
Loading xslF345X03/lamothe.xml…